Pafolacianine Sodium Patent Expiration
Pafolacianine Sodium is used for aiding in the intraoperative identification of malignant lesions in adult patients with ovarian cancer. It was first introduced by On Target Laboratories Inc
Pafolacianine Sodium Patents
Given below is the list of patents protecting Pafolacianine Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Cytalux | US10881747 | Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors | Aug 26, 2033 | On Target Labs |
| Cytalux | US9061057 | Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors | Aug 26, 2033 | On Target Labs |
| Cytalux | US9254341 | Methods of manufacture of pteroyl-amino acid-fluorescent dyes | Oct 04, 2033 | On Target Labs |
| Cytalux | US9333270 | Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors | Aug 26, 2033 | On Target Labs |
| Cytalux | US9341629 | Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors | Aug 26, 2033 | On Target Labs |
| Cytalux | US9789208 | Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors | Aug 26, 2033 | On Target Labs |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳